ST. GALLEN, SWITZERLAND, March 19, 2024 /PRNewswire/ -- CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron ...
Results of a subanalysis from the FAIR-HF (Ferinject(R) Assessment in patients with IRon deficiency and Chronic Heart Failure) study demonstrate that correcting iron deficiency with Ferinject(R) ...
Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions virtual congress. Simultaneously, results were published in the ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221127005020/en/ CSL Vifor and Fresenius Kabi today ...
17 August 2011 London: Hikma Pharmaceuticals (LSE: HIK) (NASDAQ Dubai: HIK) ("Hikma"), the fast growing pharmaceutical company, today announces that its wholly-owned subsidiary Hikma Pharmaceuticals ...
Sign up to receive daily headline news from Ottawa Citizen, a division of Postmedia Network Inc. CSL Vifor and Fresenius Kabi today announced that China’s National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results